Drug
ZN-c5
ZN-c5 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
Ph phase_1
5
100%
Phase Distribution
5
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
5(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 15 (100.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
A Study of ZN-c5 in Subjects With Breast Cancer
NCT03560531
completedphase_1
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
NCT04514159
completedphase_1
A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS
NCT04852419
completedphase_1
A Study of ZN-c5 in Participants With Breast Cancer
NCT04176757
completedphase_1
A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects
NCT04561752
Clinical Trials (5)
Showing 5 of 5 trials
NCT03560531Phase 1
A Study of ZN-c5 in Subjects With Breast Cancer
NCT04514159Phase 1
A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer
NCT04852419Phase 1
A PHASE 1B STUDY OF ZN-C5 IN CHINESE SUBJECTS
NCT04176757Phase 1
A Study of ZN-c5 in Participants With Breast Cancer
NCT04561752Phase 1
A Food Effect Study With ZN-c5 in Healthy Post-Menopausal Subjects
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5